In-Depth Controlled Substances Market Analysis for 2020 and Beyond


Controlled Substances market research study in brief

The business intelligence study for the Controlled Substances market provides an extensive synopsis of essential aspects involving the product classification, important definitions, and other industry-specific parameters. The report also covers the key factors associated with the current events such as alliances, mergers & acquisitions, and new product launches.

Additionally, the Controlled Substances market study puts forth a rigid basis for collecting a cluster of insights that potential customers can use to enhance their revenues and reduce costs. The illustration of data on Controlled Substances market segmentation by type, application, and geography offers a critical viewpoint of, what manufacturers are eyeing for the stipulated timeframe, 2019 – 2026.

This article will help the Controlled Substances vendors understand the volume expansion outlook with impacting trends.

Request Sample Report @

All of the segments covered in the research study are examined on the basis of BPS, market share, revenue, and other crucial factors. Our business study presents how various segments are adding to the growth of the global Controlled Substances market. It also offers information on key trends with regards to the segments studied in the report. This supports market players to focus on promising regions of the global Controlled Substances market. The research study also delivers independent analysis on the segments as per absolute dollar opportunity.

Competition Landscape 

  • GW Pharmaceuticals has announced its plan of epidiolex (CBD or cannabidiol) development program in 2018, to combat infantile spasms, which according to the company is the fourth largest target indication for its program of epidiolex orphan pediatric epilepsy development.
  • Molecular Science Corporation and Canopy Growth entered into a strategic collaboration in 2018, to pioneer standardized testing methods for analyzing and enhancing the efficacy of cannabis testing, its safety awareness and product knowledge.
  • Aphria Incorporation has signed an exclusive agreement with Colcanna SAS for extending its medical cannabis sales in Columbia. Aphria eyes to leverage the large distribution footprint of Colcanna SAS to market its MMJ products in Columbia.

Key players operating in the controlled substances market, as identified in the report, include CANNABIS SATIVA, INC., The Peace Naturals Project, Canopy Growth Corporation, GW PHARMACEUTICALS PLC, Takeda Pharmaceutical Company Limited, Teva Pharmaceuticals, Inc., Mallinckrodt plc, SAFC/Cerilliant, Noramco, Inc., Johnson Matthey, Siegfried AG, AMRI, Cayman Chemical, Consort Medical, Patheon, and Cambrex. 

controlled substances market competition canvas

Get the summary of the report to get more information on the competition landscape of the controlled substances market.

Additional Insights

Electronic Prescribing of Controlled Substances – A Key Trend 

Electronic prescribing of controlled drugs, which emerged as a key trend in the past decade focusing on adoption and utility, has witnessed a paradigm shift toward quality- and optimization-based developments in the past few years. This has further led to an increased efficiency of processes associated with physicians, such as reduced follow-up times for detecting errors owing to time saved from procuring them electronically. Encouraging access to electronic health records for the same has further resulted in timely product validation and verification prior to procurement. As of 2018, nearly 22 states in the US have current or impending legislations for electronic prescribing of controlled substances. 

New Laws Implemented on Opioids 

The Opioid Reduction Act was implemented by the West Virginia Department of Health and Human Resources, setting limitations on the opioid prescriptions, and enabling patients to place directives in their medical files apropos of advanced treatment that involve opioid medications. Additionally, the legislation enables patients top opt out of treatment with opioids in advance, via filling the form of Voluntary Opioid Advanced Directive. This initiative to reduce the use of opioids, particularly for beginners, is a huge step taken toward turning the tap off in opioid crisis, while preventing new patients from getting addicted to these drugs.

Scope of the Report  

controlled substances market taxonomy

Research Methodology 

This report offers holistic insights on the controlled substances market, along with important numbers such as revenue comparison, Y-o-Y growth comparison, and market share comparison of key segmented identified in the controlled substances market. Key trend affecting the growth of the controlled substances market have also been analyzed in the report, along with their degree of impact intensity on the controlled substances market. 

Insights and analysis offered on the controlled substances market in this report are backed by a robust research methodology, which involves a perfect combination of extensive primary and secondary researches. The year 2017 is considered as the base year for forecasting further projections of the controlled substances market for the period between 2018 and 2028. 

Comprehensive telephonic interviews have been conducted for gaining first-hand, authoritative information on the controlled substances market’s current scenario and prospects. This information is then used for validating the insights gained from exhaustive secondary researches. 

This research methodology adopted for compiling the report on the controlled substances has enabled our analysts to deduce holistic insights into the controlled substances market’s growth prospects. This report serves as an authentic dataset for clients to further their business growth with precarious steps in their future business trajectory.

Research Methodology of this Report.

Limited Time Offer for New Market Entrants to Buy their Copy at a Discounted Rate!!!

Request Methodology On This Report @

The research attempts to answer many queries such as:

  1. What aspects do the customers look for while purchasing Controlled Substances ?
  2. Who is buying your product or service globally at present?
  3. Who are your critical competitors?
  4. How will the competitive scenario look like between the forecast period 2018 to 2025?
  5. What will be the cost of the products and facilities across different regions?
  6. What are the trends impacting the performance of the Controlled Substances market?
  7. What issues will vendors running the Controlled Substances market confront?
  8. What needs are the leading manufacturers trying to meet by the forecast period 2025?

Why Choose Fact.MR?

  1. Multi-Disciplinary Approach to Solve Market Challenges
  2. Accurate Regional Demand Estimation And Forecast
  3. Data Acquisition from Trusted Multidimensional Sources
  4. Real-Time Competitive Breakdown
  5. Customized Business Solutions

Ask analyst about this report at


About Fact.MR

Fact.MR is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. Fact.MR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.